Behavior, Addictive clinical trials
The registry lists 521 studies for Behavior, Addictive across more than 10 countries. 124 are recruiting or about to start. 122 of them are mainly about Behavior, Addictive (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 4 narrower conditions too, such as Internet Addiction Disorder: 743 studies, 182 open.
Get an email when these change. Save the Behavior, Addictive studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Medical University of South Carolina (15) · Yale University (13) · Assistance Publique - Hôpitaux de Paris (11) · Johns Hopkins University (11) · National Institute on Drug Abuse (NIDA) (10) · Centre for Addiction and Mental Health (9) · Assiut University (8) · University of California, Los Angeles (8)
What is being tested here
Drugs under test in Behavior, Addictive studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Semaglutide | 4 | 0 | 6 |
| Tirzepatide | 3 | 0 | 3 |
| Psilocybin | 2 | 0 | 5 |
| Ethanol | 2 | 0 | 4 |
| Naltrexone | 1 | 5 | 14 |
| Nicotine | 1 | 0 | 3 |
| Cytisine | 1 | 1 | 2 |
| Glucagon-Like Peptide 1 | 1 | 0 | 1 |
| Lemborexant | 1 | 0 | 1 |
| Daridorexant | 1 | 0 | 1 |
Drug classes tested here GLP-1 receptor agonists 6 open · Opioid antagonists 1 open · Opioids 7 · Stimulants 5 · Antipsychotics 4
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest
- Nov 2026University Survey on Consumer Behavior and Mental Health · University Hospital, Strasbourg, France
- Nov 2026Tirzepatide Impact Assessment Study · Texas Tech University
- Nov 2026THE EFFECT OF A TRANSTHEORETICAL MODEL-BASED CHATBOT SUPPORT INTERVENTION ON SMOKING BEHAVIOR IN UNIVERSITY STUDENTS · Seher DÖNER
- Nov 2026ACT Lung Health Intervention: Phase Two · Dana-Farber Cancer Institute
- Dec 2026Supporting Treatment Access and Recovery Through Linkage and Support · University of Massachusetts, Worcester
- Dec 2026Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites · University of Chicago
- Dec 2026Nalmefene Implant in Healthy Subjects · ReacX Pharmaceuticals, Inc.
- Dec 2026Screen Addiction and Postoperative Pain · Tokat Gaziosmanpasa University
- Dec 2026Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care · Johns Hopkins University
- Dec 2026Smoking Cessation With Wearables to Improve General, Oral Health and Quality of Life · University of Salerno
Who these studies take
Of the 79 Behavior, Addictive studies recruiting now, 44 (56%) set no upper age limit and 33 (42%) stop at 75 or younger. 7 (9%) take children under 18. 4 (5%) are for women only and 1 (1%) for men only; 23 (29%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (3%) | 2 (3%) |
| 18 | 63 (80%) | 60 (76%) |
| 30 | 71 (90%) | 68 (86%) |
| 40 | 71 (90%) | 68 (86%) |
| 50 | 70 (89%) | 67 (85%) |
| 65 | 65 (82%) | 62 (78%) |
| 75 | 49 (62%) | 47 (59%) |
| 85 | 45 (57%) | 43 (54%) |
Across all 521 studies, recruiting or not: 56% stop at 75 or younger and 48% at 65; 14% take children; 4% are for women only and 5% for men only; 31% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Behavior, Addictive studies take
Of 23 phase 1 interventional studies under Behavior, Addictive, half reached primary completion within 23 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 23 mo11–47 · 23 studies | — | — |
| Phase 2 | 43 mo31–59 · 23 studies | — | — |
| Interventional, no phase | 26 mo10–42 · 155 studies | — | 27 mo10–42 · 147 studies |
| Observational | 40 mo20–73 · 49 studies | — | 40 mo20–111 · 46 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting2
- Support Towards Addiction Recovery for Individuals With Criminal Legal System Involvement: The STAR ProjectOct 22, 2026NCT07596251
- Peer Support in Alcohol DependenceOct 21, 2026NCT06381609
Newly registered2
- THE EFFECT OF A TRANSTHEORETICAL MODEL-BASED CHATBOT SUPPORT INTERVENTION ON SMOKING BEHAVIOR IN UNIVERSITY STUDENTSOct 21, 2026NCT07887217
- Vocal Biomarkers of CravingOct 16, 2026NCT07878624
Studies
Recruiting first, then most recently updated. Showing 50 of 521. Browse all 521 → or search them.
- Trial of Social Work Services in Fracture Clinic SettingRecruitingNCT06973655Not applicable2 countries
- The Impact of Equine-Assisted Therapy on Mental Health and Addictive Behaviors in Patients Receiving Addiction TreatmentNot yet recruitingNCT07495839Not applicable
- Open-Label Psilocybin Study in Transdiagnostic PopulationRecruitingNCT06442423Phase 11 country
- Tdcs And cogNitive traininG cOmbined for AUD (TANGO)RecruitingNCT05062369Not applicable1 country
- Ecological Momentary Assessment of State-Dependent Decision-Making and Metacognition Across a Psychopathology ContinuumNot yet recruitingNCT078010791 country
- QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)Not yet recruitingNCT07661823Not applicable1 country
- Addiction Potential of Very Low Nicotine Filtered Little CigarsRecruitingNCT06630728Phase 41 country
- Outcome Inference in the Sensory Preconditioning Task in Opioid-Use DisorderRecruitingNCT037453391 country
- Attachment and Prognostic Factor: the Implicit ApproachNot yet recruitingNCT04954027
- Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With MusicRecruitingNCT07028983Not applicable8 countries
- Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and EngagementRecruitingNCT06461962Not applicable1 country
- Support Towards Addiction Recovery for Individuals With Criminal Legal System Involvement: The STAR ProjectRecruitingNCT07596251Not applicable1 country
- Peer Support in Alcohol DependenceRecruitingNCT06381609Not applicable1 country
- Vocal Biomarkers of CravingRecruitingNCT078786241 country
- Adapting and Implementing a Chronic Disease Self-Management Program for Primary Care Patients With Opioid Use Disorder and Serious Mental IllnessNot yet recruitingNCT07865078Not applicable
- Is Craving a Central Criterion for Diagnosing a Behavioral Addiction?RecruitingNCT078549121 country
- Cannabis' Impact on Alcohol ConsumptionRecruitingNCT05389930Phase 21 country
- Screen Addiction and Postoperative PainEnrolling by invitationNCT072428721 country
- Combination Therapy for Alcohol Use DisorderNot yet recruitingNCT07249554Phase 21 country
- Lemborexant for Cannabis Use DisorderNot yet recruitingNCT07802990Phase 1/21 country
- Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)RecruitingNCT07145866Phase 41 country
- A Study of the Correlation Between the Severity of Substance Use Disorder and the Intensity of Dependence on Generative Artificial IntelligenceNot yet recruitingNCT07819851Not applicable1 country
- Mobile Application-Based Interventions for Cannabis Use in Young Adults With First Episode PsychosisNot yet recruitingNCT07811466Not applicable
- Deep Brain Stimulation Effects In Patients With Opioid Use DisorderRecruitingNCT04354077Not applicable1 country
- GLP-1R Agonist Treatment for Opioid Use DisorderRecruitingNCT06548490Phase 21 country
- Evaluation of Community Health Worker Support to Help People With Serious Mental Illness to Quit SmokingNot yet recruitingNCT07789132Not applicable1 country
- A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free HomeRecruitingNCT06693700Not applicable1 country
- téléwork and Consumer Behavior: Longitudinal StudyRecruitingNCT077883521 country
- Connecting Loved Ones to Support and Empowering RecoveryRecruitingNCT07740395Not applicable1 country
- Supportive Treatment With Enhanced Post-Incarceration ServicesNot yet recruitingNCT07744841Not applicable
- Tirzepatide Impact Assessment StudyRecruitingNCT07740291Not applicable1 country
- A Novel Adaptation of the Unified Protocol (UP) as a Transdiagnostic Intervention for Emotional Disorders in Addictive BehaviorsEnrolling by invitationNCT07738081Not applicable1 country
- Repetitive Transcranial Magnetic Stimulation for People With Etomidate Addiction (SToP-E-rTMS x Etomidate)Not yet recruitingNCT07736742Not applicable1 country
- Role of Craving in the Transition Across Level of Addiction Severity: A Longitudinal Study.RecruitingNCT077343631 country
- University Survey on Consumer Behavior and Mental HealthNot yet recruitingNCT077218961 country
- Psychosocial Support for Nitrous Oxide MisuseNot yet recruitingNCT07716293Not applicable1 country
- Multi-Site Trial of Tirzepatide for Smoking CessationRecruitingNCT07602699Phase 21 country
- Better Access to and Integration of Mental Health and Addiction Services Through Navigation: A Mixed-Methods Adaptive Pragmatic Clinical TrialNot yet recruitingNCT07707492Not applicable1 country
- The Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals With Tiletamine Use DisorderNot yet recruitingNCT07689981Not applicable1 country
- Implementation of Tobacco Cessation Programming at Community Behavioral Health SitesRecruitingNCT06837220Not applicable1 country
- Comparative Evaluation of Nicotine AnalogsRecruitingNCT07585006Phase 11 country
- Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT StudyNot yet recruitingNCT07509112Phase 21 country
- Mobile Restriction on Dopamine TransporterRecruitingNCT07663474Not applicable1 country
- PASCAL Feasibility StudyRecruitingNCT07301151Not applicable1 country
- Ketamine for Combined Depression and Alcohol Use DisorderRecruitingNCT06090422Phase 1/21 country
- Neuroimaging of Adolescent Cannabis Use TreatmentRecruitingNCT07340554Not applicable1 country
- Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en AlcoolRecruitingNCT06618755Not applicable1 country
- Designing a Smoking Intervention for Youth SmokersNot yet recruitingNCT07178899Not applicable1 country
- Impulsivity Domains and Subjective ResponseRecruitingNCT05929677Early Phase 11 country
- NLP Analysis of Weekly Narratives for Dynamic Clinical Assessment in SUDRecruitingNCT075956141 country